References
- 1. Llach F: Hypercoagulability, renal vein thrombosis, and other thrombotic complications of nephrotic syndrome. Kidney Int. 1985; 28:429.
- 2. Singhal R, Brimble KS: Thromboembolic complications in the nephrotic syndrome: pathophysiology and clinical management. Thromb Res. 2006; 118:397.
- 3. Wei LQ, Rong ZK, Gui L, Shan RD: CT diagnosis of renal vein thrombosis in nephrotic syndrome. J Comput Assist Tomogr. 1991; 15:454.
- 4. Llach F, Papper S, Massry SG: The clinical spectrum of renal vein thrombosis: acute and chronic. Am J Med. 1980; 69:819.
- 5. Wagoner RD, Stanson AW, Holley KE, Winter CS: Renal vein thrombosis in idiopathic membranous glomerulopathy and nephrotic syndrome: incidence and significance. Kidney Int. 1983; 23:368.
- 6. Sarasin FP, Schifferli JA: Prophylactic oral anticoagulation in nephrotic patients with idiopathic membranous nephropathy. Kidney Int. 1994; 45:578.
- 7. Robert A, Olmer M, Sampol J, Gugliotta JE, Casanova P: Clinical correlation between hypercoagulability and thrombo-embolic phenomena. Kidney Int. 1987; 31:830 - 5.
- 8. Barbour SJ, Greenwald A, Djurdjev O, Levin A, Hladunewich NA, Nachman PH et al: Disease-specific risk of venous thromboembolic events is increased in idiopathic glomerulonephritis. Kidney Int. 2012; 81:190.
- 9. Lionaki S, Derebail VK, Hogan SL, Barbour SJ, Lee T, Hladunewich NA et al: Venous thromboembolism in patients with membranous nephropathy. Clin J Am Soc Nephrol. 2012; 7:43.
- 10. Levey AS, Greene T, Kusek JW, Beck GJ, MDRD Study Group: A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol., 2000, 11:A0828.
- 11. Andrassy K, Ritz E, Bommer J: Hypercoagulability in the nephrotic syndrome. Klin Wochenschr. 1980; 58:1029-36.
- 12. Cameron JS. The nephrotic syndrome and its complications. Am. J. Kidney Dis. 1987 Sep;10(3):157-71.
- 13. Di Nisio M, Squizzato A, Rutjes AW, Buller HR, Zwinderman AH, Bossuyt PM: Diagnostic accuracy of Ddimer test for exclusion of venous thromboembolism: A systematic review. J Thromb Haemost 2007; 5: 296 -304.
- 14. Mannucci PM, Valsecchi C, Bottasso B, D’Angelo A, Casati S, Ponticelli C: High plasma levels of protein C activity and antigen in the nephritic syndrome. Thromb Haemost 1986; 55(1): 31-33.
- 15. Haifeng Wu, Birmingham DJ, Rovin B, Hackshaw KV, Haddad N, Haden D et al: D-Dimer level and the risk for thrombosis in systemic lupus erythematosus.Clin J Am Soc Nephrol. 2008; 3: 1628-1636.
- 16. Mahmoodi BK, ten Kate MK, Waanders F, Veeger NJ, Brouwer JL, Vogt L et al: High absolute risks and predictors of venous and arterial thromboembolic events in patients with nephrotic syndrome: results from a large retrospective cohort study. Circulation 2008; 117:224.
- 17. Glassock RJ: Prophylactic Anticoagulation in Nephrotic Syndrome: A Clinical Conundrum. J Am Soc Nephrol. 2007;18: 2221-2225.
- 18. Kauffrnann RH, Veltkamp JJ, Van Tilburg NH, Van Es LA: Acquired antithrombin III deficiency and thrombosis in the nephrotic syndrome. Am J Med. 1978;65:607-13.
- 19. Boneu B, Bouissou F, Abbal M, Sie P, Caranobe C, Barthe P: Comparison of progressive antithrombin activity and the concentration of three thrombin inhibitors in nephrotic syndrome. Thromb Haemost. 1981;46:623-5.
- 20. Chemg SC, Huang WS, Wang YF, Yang SP, Lin YF: The role of lung scintigraphy in the diagnosis of nephrotic syndrome with pulmonary embolism. Clin Nucl Med 2000; 25:167- 72.
- 21. Citak A, Emre S, Sairin A, Bilge I, Nayir A: Hemostatic problems and thromboembolic complications in nephrotic children. Pediatr Nephrol 2000;14:138- 42.
- 22. Vaziri ND, Gonzales EC, Shayestehfar B, Barton CH: Plasma levels and urinary excretion of fibrinolytic and protease inhibitory proteins in nephrotic syndrome. J Lab Clin Med 1994; 124(1):118-124.
- 23. Hamano K, Iwano M, Akai Y, Sato H, Kubo A, Nishitani Y et al: Expression of glomerular plasminogen activator inhibitor type 1 in glomerulonephritis. Am J Kidney Dis 2002; 39:695- 705.